Inhibition of miR-21 in mdx mice as well as in DMD fibroblasts reinstates expression of PTEN and SPRY-1 along with decreases in the expression of COL1A1 and COL6A; thereby, improving the disease phenotype (132). The gene discussed is SPRY1; the disease is Duchenne muscular dystrophy.